Immunic, Inc.

IMUX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$35,132$55,310$14,304$35,668
Short-Term Investments$0$0$0$0
Receivables$0$594$631$684
Inventory$0$0$0$0
Other Curr. Assets$4,141$3,938$4,040$2,980
Total Curr. Assets$39,273$59,842$18,975$39,332
Property Plant & Equip (Net)$1,431$1,587$1,540$1,536
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,431$1,587$1,540$1,536
Other Assets$0$0$0$0
Total Assets$40,704$61,429$20,515$40,868
Liabilities
Payables$7,918$7,893$5,507$7,846
Short-Term Debt$0$774$765$740
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$22,161$18,646$19,320$13,589
Total Curr. Liab.$30,079$27,313$25,592$22,175
LT Debt$126$205$210$264
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$126$205$210$264
Other Liabilities$0$0$0$0
Cap. Leases$126$979$975$1,004
Total Liabilities$30,205$27,518$25,802$22,439
Equity
Pref Stock$0$0$0$0
Common Stock$9$9$8$8
Retained Earnings-$589,271-$563,692-$536,872-$511,399
AOCI$2,582$2,525$3,924$4,209
Other Equity$597,179$595,069$527,653$525,611
Total Equity$10,499$33,911-$5,287$18,429
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$40,704$61,429$20,515$40,868
Net Debt-$35,006-$54,331-$13,329-$34,664
Immunic, Inc. (IMUX) Financial Statements & Key Stats | AlphaPilot